NCT00493155View on ClinicalTrials.gov

A Multiple Ascending Dose Study of R1530 in Patients With Advanced Solid Tumors.

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

February 28, 2009

Study Completion Date

February 28, 2009

Conditions
Neoplasms
Interventions
DRUG

RG1530

Administered po at escalating doses (10 cohorts)

Trial Locations (6)

48201

Detroit

77030

Houston

89135

Las Vegas

02114-2696

Boston

02115

Boston

02215

Boston

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT00493155 - A Multiple Ascending Dose Study of R1530 in Patients With Advanced Solid Tumors. | Biotech Hunter | Biotech Hunter